Please note this is an extract of the original bulletin.
MHRA’s new International Recognition Procedure (IRP) goes live from 1 January 2024*
Page summary:
In partnership with other global regulators, IRP is expected to further help bring life-saving new medicines to UK patients.
Change made:
First published.
*Please note this update does not include medical and IVD devices.
Unfettered Access Procedure for marketing authorisations approved in Northern Ireland
Page summary:
Guidance for holders of Marketing Authorisations approved in Northern Ireland or the EU/EEA member states who want to bring a product to market in Great Britain.
Change made:
Added link to Fees Calculator.
